跳至主要内容
临床试验/NCT02325063
NCT02325063终止不适用

Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms

Centre Hospitalier Universitaire de Nīmes2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2015年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
13
试验地点
2
主要终点
Visual analog scale (VAS) for pain over the last 24 hours

研究概览

简要总结

The primary objective of this study is to compare the evolution of pain profiles among patients suffering from lateral epicondyalgia (tennis elbow) following three types of treatment: PRP-L injection versus type A botulinum toxin injection versus corticoid injection.

详细描述

The secondary objectives are to compare the following among the three groups:

A- The global efficacy of each treatment defined by a minimum reduction of 25% in average pain over the last 24 hours between 0 and 6 months.

B- The evolution of average pain over the last 24 hours between 0 and each different time frame (3 weeks, 6 weeks, 3 months and 6 months).

C- The evolution of maximum pain scores using nocturnal post-effort (Jamar grip test) visual analog scales (VAS) between day 0, 3 weeks, 6 weeks, 3 months and 6 months.

D- The perception of change on the Patient's Global Impression of Change score (PGIC) at 3 and 6 months E- The evolution of PRTEE scores at 0, 3 and 6 months F- Adverse events at 3 weeks, 6 weeks, 3 months and 6 months. G - Quality of life and utility via the SF-12 at 3 and 6 months. H- The consumption of analgesics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

PRP-L Group

Experimental

Patients randomized to this group will be treated with an injection of Leukocyte and Platelet Rich Plasma (PRP-L).

Intervention: PRP-L Injection

干预措施: PRP-L Injection (Drug)

Botox Group

Active Comparator

Patients randomized to this group will be treated with an injection of Type A Botulinum Toxin (Xeomin®, MERZ).

Intervention: Botox injection

干预措施: Botox injection (Drug)

Corticoid Group

Active Comparator

Patients randomized to this group will be treated with an injection of Corticoids.

Intervention: Corticoid injection

干预措施: Corticoid injection (Drug)

结局指标

主要结局

Visual analog scale (VAS) for pain over the last 24 hours

时间窗: 6 months versus Baseline (day 0)

score varying from 0 to 10

次要结局

  • Visual analog scale for pain over the last 24 hours(3 months)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验